Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,281 | 472 | 99.8% |
| Education | $13.92 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,256 | 105 | $0 (2024) |
| Novo Nordisk Inc | $700.57 | 47 | $0 (2024) |
| Lilly USA, LLC | $639.25 | 41 | $0 (2024) |
| Amgen Inc. | $578.26 | 34 | $0 (2024) |
| Axsome Therapeutics, Inc. | $342.98 | 18 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $334.36 | 22 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $290.29 | 19 | $0 (2024) |
| PFIZER INC. | $262.03 | 17 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $251.87 | 17 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $239.04 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,952 | 119 | ABBVIE INC. ($313.86) |
| 2023 | $1,999 | 133 | ABBVIE INC. ($364.30) |
| 2022 | $1,629 | 103 | Amgen Inc. ($188.43) |
| 2021 | $1,715 | 118 | AbbVie Inc. ($390.11) |
All Payment Transactions
473 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Gastroenterology | ||||||
| 12/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: PSYCHIATRY | ||||||
| 12/18/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: RESPIRATORY | ||||||
| 12/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: PAIN | ||||||
| 12/10/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: DERMATOLOGY | ||||||
| 12/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: NEUROSCIENCE | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.33 | General |
| Category: Gastroenterology | ||||||
| 11/21/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $21.86 | General |
| Category: NEUROLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/14/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $2.77 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: PSYCHIATRY | ||||||
| 11/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: PAIN | ||||||
| 11/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: Gastroenterology | ||||||
| 10/29/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.53 | General |
| Category: Cardiovascular | ||||||
| 10/28/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Inflammation | ||||||
| 10/22/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $100.50 | General |
| Category: Hematology | ||||||
| 10/16/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 10/15/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/09/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $11.37 | General |
| Category: Obesity | ||||||
| 10/01/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $8.29 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,251 | 1,710 | $178,466 | $75,641 |
| 2022 | 21 | 958 | 1,269 | $150,230 | $64,234 |
| 2021 | 17 | 819 | 1,059 | $114,983 | $48,912 |
| 2020 | 8 | 491 | 585 | $52,671 | $26,299 |
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 248 | 428 | $86,456 | $32,687 | 37.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 138 | 180 | $24,660 | $9,793 | 39.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 84 | 84 | $18,396 | $9,004 | 48.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 24 | 24 | $7,700 | $6,780 | 88.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 15 | 15 | $6,540 | $2,817 | 43.1% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 50 | 52 | $4,160 | $2,589 | 62.2% |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | Office | 2023 | 24 | 24 | $3,600 | $2,253 | 62.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 25 | 25 | $2,125 | $1,795 | 84.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 164 | 238 | $5,950 | $1,785 | 30.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 128 | 170 | $1,893 | $1,412 | 74.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 61 | 97 | $4,559 | $883.47 | 19.4% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 37 | 40 | $4,600 | $877.42 | 19.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 25 | 25 | $1,250 | $753.75 | 60.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 24 | 24 | $1,200 | $723.60 | 60.3% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 108 | 136 | $1,632 | $422.96 | 25.9% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 14 | 14 | $1,190 | $356.59 | 30.0% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 34 | 37 | $999.00 | $344.68 | 34.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 19 | 19 | $1,050 | $176.40 | 16.8% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 14 | 14 | $378.00 | $163.15 | 43.2% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 15 | 64 | $128.00 | $25.21 | 19.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 230 | 335 | $67,670 | $25,668 | 37.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 80 | 80 | $17,520 | $8,859 | 50.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 121 | 147 | $20,139 | $8,237 | 40.9% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 21 | 21 | $9,156 | $4,017 | 43.9% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 60 | 68 | $5,440 | $3,452 | 63.5% |
About Kelsey Stapleton, PA-C
Kelsey Stapleton, PA-C is a Physician Assistant healthcare provider based in Abingdon, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/25/2018. The National Provider Identifier (NPI) number assigned to this provider is 1609364785.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kelsey Stapleton, PA-C has received a total of $7,295 in payments from pharmaceutical and medical device companies, with $1,952 received in 2024. These payments were reported across 473 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($7,281).
As a Medicare-enrolled provider, Stapleton has provided services to 3,519 Medicare beneficiaries, totaling 4,623 services with total Medicare billing of $215,085. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Other Specialties Physician Assistant
- Location Abingdon, VA
- Active Since 04/25/2018
- Last Updated 10/31/2021
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1609364785
Products in Payments
- VRAYLAR (Drug) $473.33
- UBRELVY (Drug) $440.51
- Wegovy (Drug) $354.30
- TRINTELLIX (Drug) $334.36
- Auvelity (Drug) $310.93
- TRULICITY (Drug) $301.11
- XIFAXAN (Drug) $290.29
- Otezla (Drug) $252.86
- Aimovig (Biological) $240.71
- QULIPTA (Drug) $225.04
- JARDIANCE (Drug) $218.46
- NURTEC ODT (Drug) $213.12
- Ozempic (Drug) $177.25
- MOUNJARO (Drug) $174.45
- XARELTO (Drug) $156.30
- QUVIVIQ (Drug) $149.28
- Kerendia (Drug) $146.68
- NEXLETOL (Drug) $145.22
- TRELEGY ELLIPTA (Drug) $143.57
- EMGALITY (Drug) $132.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Abingdon
Mr. James Mccloskey, Pa-C, PA-C
Physician Assistant — Payments: $3,989
Miss. Cathy Hopkins, Pa, PA
Physician Assistant — Payments: $2,119
Sara Thead, Pa-C, PA-C
Physician Assistant — Payments: $1,897
Kelsie Addison
Physician Assistant — Payments: $1,509
Megan Walker, Pa-C, PA-C
Physician Assistant — Payments: $1,246
Scott Hunter, Pac, PAC
Physician Assistant — Payments: $435.87